Close X
Monday, November 25, 2024
ADVT 
International

EU regulator starts safety review of coronavirus drug

Darpan News Desk The Canadian Press, 02 Oct, 2020 11:27 PM
  • EU regulator starts safety review of coronavirus drug

The European Medicines Agency says it has started a safety review after some patients taking the coronavirus drug remdesivir reported serious kidney problems.

In a statement on Friday, the EU regulator said it isn’t clear whether remdesivir was causing the “acute kidney injury,” but that the issue “warrants further investigation.”

Remdesivir was given a conditional marketing authorization by the EMA on July 3 and can be used to treat people older than age 12 with severe COVID-19 and pneumonia who require oxygen treatment. The approval for the drug was fast-tracked with the understanding that more evidence would be submitted after a license was granted.

“The benefits to these severely ill patients outweigh the risks of making the medicine available despite having less complete data than normally expected,” the EMA said.

Remdesivir is one of the few licensed treatments for the coronavirus, in addition to the generic steroid dexamethasone. In July, health experts criticized the United States for buying up a significant portion of the drug, made by Gilead Sciences.

The European Medicines Agency said the potential problem of kidney toxicity caused by remdesivir was evaluated when the conditional approval was given but that analysis was mainly based on animal studies. It noted that kidney injuries can be caused by other factors, including diabetes and the coronavirus itself.

The regulator said recommendations for the use of remdesivir remain unchanged; doctors are already advised to monitor patients for kidney complications prior to starting treatment and not to use the drug in patients with known kidney problems.

The agency said “enhanced safety monitoring” is in place to detect potentially worrying and unexpected side effects from remdesivir through monthly safety reports.

Early studies testing remdesivir in patients hospitalized with COVID-19 found that those who received the treatment recovered quicker than those who didn’t.

On Thursday, the EMA said it had begun the process of potentially fast-tracking approval for an experimental COVID-19 vaccine developed by Oxford University and AstraZeneca.

MORE International ARTICLES

Guru Nanak's Principles More Relevant Today, Say US Lawmakers

Republican Senator from Indiana Todd Young, who has introduced a resolution in the Senate on the occasion, said the Sikh-Americans had succeeded in making a profound impact across the US because they followed the teachings of the first Sikh guru.    

Guru Nanak's Principles More Relevant Today, Say US Lawmakers

Imran Khan's Ex-Wife Reham Khan Wins Defamation Case Against Pakistani News Channel

Imran Khan's Ex-Wife Reham Khan Wins Defamation Case Against Pakistani News Channel
Pakistan Prime Minister Imran Khan's former wife, Reham Khan, has won "substantial" damages and received an apology from a Pakistani news channel over defamatory allegations by a government minister during a show last year.    

Imran Khan's Ex-Wife Reham Khan Wins Defamation Case Against Pakistani News Channel

UK General Election: Labour Party’s Diaspora Group Slams Lack Of Indian-Origin Candidates

Labour Friends of India (LFIN), the representative diaspora group of the UK’s Opposition Labour Party, on Wednesday issued a sharp rebuke of its party’s failure to select enough Indian-origin candidates to contest the December 12 General Election.    

UK General Election: Labour Party’s Diaspora Group Slams Lack Of Indian-Origin Candidates

Pakistan To Reopen Closed Hindu Temples

Pakistan To Reopen Closed Hindu Temples
Considering the long-standing demand of Pakistan's Hindu community, the Imran Khan government has decided to reopen the closed Hindu temples and also renovate them.

Pakistan To Reopen Closed Hindu Temples

Kulbhushan Jadhav Appeal In Civilian Court: Pak Army Denies Move

The Pakistani military has scotched reports that Pakistan is to amend the Army Act to allow Indian national Kulbhushan Jadhav the right to file an appeal in a civilian court.    

Kulbhushan Jadhav Appeal In Civilian Court: Pak Army Denies Move

Labour Does U-Turn, Disowns Corbyn's Anti-India Stance

In a move that is surely going to embarrass Jeremy Corbyn, the Chair of the Labour Party Ian Lavery has outrightly disowned Corbyn's views on Jammu and Kashmir.    

Labour Does U-Turn, Disowns Corbyn's Anti-India Stance